Jenny Ahlstrom Recognized Among Nation's Top Female Founders by Inc.

We're thrilled to share some exciting news! Our CEO and Founder, Jenny Ahlstrom, has been named to Inc.'s 2025 Female Founders 500 list. This recognition celebrates the most innovative women entrepreneurs who are making a real difference in the world, and we couldn't be prouder of Jenny's inclusion among these remarkable leaders.
As many in our community know, Jenny's journey is deeply personal. As a multiple myeloma patient herself, she understood firsthand the frustrations and challenges that cancer patients face. This personal experience drove her to create something truly transformative – a platform that bridges the gap between patients and researchers in ways never done before.
Under Jenny's leadership, HealthTree Foundation is pioneering a revolutionary cancer research approach. We've developed a comprehensive suite of over 14 integrated technology abilities that do something amazing: they give patients the power to actively contribute to finding cures. Our platform can support all cancers, making us a leader in Digital Health Advocacy.
This recognition is particularly meaningful because it acknowledges our unique approach to solving one of healthcare's biggest challenges. Traditional cancer research often struggles with limited access to patient data, but HealthTree's direct-to-patient model is changing that narrative. By building trust and long-term relationships with patients, we're creating a more complete picture of the cancer journey that researchers can use to accelerate discoveries.
"We are revolutionizing cancer research by using technology that links patients and their data with researchers for faster cures," Jenny shared upon receiving this honor. "Providing patients with abilities that enable them to become cure contributors is the future of personalized medicine."
This recognition from Inc. comes after a rigorous selection process, during which thousands of applications were reviewed through multiple rounds of judging. The selection considered quantifiable metrics like growth and impact as well as qualitative factors that demonstrate true innovation and leadership in the field.
We're excited about this recognition not just as an award, but as a validation of our mission to transform cancer research through patient empowerment and technological innovation. With over 10,000 patients already contributing real-world data through our HealthTree Cure® Hub Registry, we're proving that when patients and researchers work together, we can accelerate the path to better treatments and cures.
Thank you to our entire community – patients, researchers, supporters, and team members – who make this work possible. This recognition belongs to all of us who believe in the power of patient-driven research to change the future of cancer care.
Ready to Become a Cure Contributor?
Are you or a loved one affected by a blood cancer? Join thousands of others who are actively contributing to blood cancer research through the HealthTree Cure Hub® Registry. Sign up today and become part of the movement transforming cancer research.
We're thrilled to share some exciting news! Our CEO and Founder, Jenny Ahlstrom, has been named to Inc.'s 2025 Female Founders 500 list. This recognition celebrates the most innovative women entrepreneurs who are making a real difference in the world, and we couldn't be prouder of Jenny's inclusion among these remarkable leaders.
As many in our community know, Jenny's journey is deeply personal. As a multiple myeloma patient herself, she understood firsthand the frustrations and challenges that cancer patients face. This personal experience drove her to create something truly transformative – a platform that bridges the gap between patients and researchers in ways never done before.
Under Jenny's leadership, HealthTree Foundation is pioneering a revolutionary cancer research approach. We've developed a comprehensive suite of over 14 integrated technology abilities that do something amazing: they give patients the power to actively contribute to finding cures. Our platform can support all cancers, making us a leader in Digital Health Advocacy.
This recognition is particularly meaningful because it acknowledges our unique approach to solving one of healthcare's biggest challenges. Traditional cancer research often struggles with limited access to patient data, but HealthTree's direct-to-patient model is changing that narrative. By building trust and long-term relationships with patients, we're creating a more complete picture of the cancer journey that researchers can use to accelerate discoveries.
"We are revolutionizing cancer research by using technology that links patients and their data with researchers for faster cures," Jenny shared upon receiving this honor. "Providing patients with abilities that enable them to become cure contributors is the future of personalized medicine."
This recognition from Inc. comes after a rigorous selection process, during which thousands of applications were reviewed through multiple rounds of judging. The selection considered quantifiable metrics like growth and impact as well as qualitative factors that demonstrate true innovation and leadership in the field.
We're excited about this recognition not just as an award, but as a validation of our mission to transform cancer research through patient empowerment and technological innovation. With over 10,000 patients already contributing real-world data through our HealthTree Cure® Hub Registry, we're proving that when patients and researchers work together, we can accelerate the path to better treatments and cures.
Thank you to our entire community – patients, researchers, supporters, and team members – who make this work possible. This recognition belongs to all of us who believe in the power of patient-driven research to change the future of cancer care.
Ready to Become a Cure Contributor?
Are you or a loved one affected by a blood cancer? Join thousands of others who are actively contributing to blood cancer research through the HealthTree Cure Hub® Registry. Sign up today and become part of the movement transforming cancer research.

about the author
Marta Llobet Canela
Marta believes that too many people still struggle to understand how our bodies work, making a cancer diagnosis even more overwhelming. With 10 years of experience in blood cancer, she transforms complex medical language into clear, accessible information, empowering patients to confidently advocate for themselves and participate in meaningful research at HealthTree. She loves exploring New York and always says yes to trying a new restaurant!
More on HealthTree Press

Get the Latest Adult T-cell Leukemia / Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.